INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CK
Carver KyleChief Financial Officer
EVMNEvommune, Inc.
Grant or award
A—
279.4K sh
Nov 5, 2025Nov 7, 2025
Page 1837 of 1855
← PrevNext →
traded Nov 5, 2025
+2d
SEC Form 4

Evidence

9
TA
Tpg Gp A, LlcFormer 10% Owner
BETABETA Technologies, Inc.
Derivative conversion
C—
1.45M sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
33.9K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
MK
McIntosh KimGVP, CONTROLLER & CAO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
2,587 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
286.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
32.3K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
MK
McIntosh KimGVP, CONTROLLER & CAO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
1,351 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
PD
Paulonis DeniseDirector, President & CEO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
76.8K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
37.5K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
90.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
SJ
Scaringe Robert JDirector, Chief Executive Officer
RIVNRivian Automotive, Inc. / DE
Disposition to issuer
D—
20.36M sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
397.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
28.7K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
GH
Goss John Howard JRSVP & President Sally Beauty
SBHSally Beauty Holdings, Inc.
Grant or award
A—
10.3K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
PD
Paulonis DeniseDirector, President & CEO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
242.6K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
SG
Spinks Mark GregoryPresident Beauty Systems Group
SBHSally Beauty Holdings, Inc.
Grant or award
A—
7,383 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
33.9K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
RG
Reinhart James G.Director, Chief Executive Officer
TDUPThredUp Inc.
Derivative conversion
C—
200.0K sh
Nov 7, 2025Nov 7, 2025
traded Nov 7, 2025
+0dSEC Form 4

Evidence

9
LW
Levin WoodrowDirector
DKNGDraftKings Inc.
Option exercise
M—
446 sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
SG
Spinks Mark GregoryPresident Beauty Systems Group
SBHSally Beauty Holdings, Inc.
Grant or award
A—
12.1K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,731
152 sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
MK
McIntosh KimGVP, CONTROLLER & CAO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
9,528 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
286.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
LW
Levin WoodrowDirector
DKNGDraftKings Inc.
Option exercise
M—
446 sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
SC
Sherman Scott CSVP, CLO and CHRO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
6,610 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
GH
Goss John Howard JRSVP & President Sally Beauty
SBHSally Beauty Holdings, Inc.
Grant or award
A—
34.6K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
GH
Goss John Howard JRSVP & President Sally Beauty
SBHSally Beauty Holdings, Inc.
Grant or award
A—
12.1K sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
DJ
Dable Habib JDirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
32.3K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
244.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
SC
Sherman Scott CSVP, CLO and CHRO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
3,885 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
90.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
32.3K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
497.7K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Option exercise
M—
3,644 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
32.3K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
66.7K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
GH
Goss John Howard JRSVP & President Sally Beauty
SBHSally Beauty Holdings, Inc.
Grant or award
A—
5,067 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence

9
MK
McIntosh KimGVP, CONTROLLER & CAO
SBHSally Beauty Holdings, Inc.
Grant or award
A—
1,661 sh
Nov 5, 2025Nov 7, 2025
traded Nov 5, 2025
+2dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Grant or award
A—
37.5K sh
Nov 6, 2025Nov 7, 2025
traded Nov 6, 2025
+1dSEC Form 4

Evidence